NEW YORK--(BUSINESS WIRE)--
Levi & Korsinsky is investigating the Board of Directors of Theragenics Corporation (“Theragenics” or the “Company”) (TGX) for possible breaches of fiduciary duty and other violations of state law in connection with the receipt of a going private proposal from Juniper Investment Company, LLC.
Click here to learn more about the investigation http://zlk.9nl.com/theragenics-tgx/, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Theragenics shareholders will receive between $2.25 and $2.30 for each share of Theragenics stock they own. The investigation concerns, among other things, whether the proposed consideration to be paid to Theragenics shareholders is unfair, inadequate, and substantially below the fair or inherent value of Theragenics. Theragenics has a reported book value of $2.66 for the most recent quarter.
If you own common stock in Theragenics and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/theragenics-tgx/.
Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
Toll Free: 877-363-5972